Oncology Institute, Inc. (TOI) Deferred Taxes (2021 - 2023)
Oncology Institute's (TOI) quarterly Deferred Taxes came in at -$126000.0 in Q4 2023, up 71.75% YoY from -$73362.9 in Q4 2022, and down 257.5% on a QoQ basis from $80000.0 in Q3 2023.
Oncology Institute, Inc. (TOI) Deferred Taxes (2021 - 2023) Analysis & Trends
Oncology Institute (TOI) has 3 years of Deferred Taxes data on file, last reported at -$126000.0 in Q4 2023.
- Quarterly Deferred Taxes rose 71.75% year-over-year to -$126000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$126000.0 (up 68.18% YoY) and the FY2025 annual result came in at -$32000.0, changed N/A from the prior year.
- Deferred Taxes retreated to -$126000.0 in Q4 2023, from $80000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $2.3 million in Q4 2021 to a low of -$3.8 million in Q3 2021.
- A 3-year average of -$143727.3 and a median of -$4000.0 in 2023 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 101.38% in 2022, down 119.43% in 2022.
- Tracing TOI's Deferred Taxes over 3 years: stood at $2.3 million in 2021, then plunged by 119.43% to -$446000.0 in 2022, then jumped by 71.75% to -$126000.0 in 2023.
- The last three Deferred Taxes figures came in at -$126000.0 (Q4 2023), $80000.0 (Q3 2023), and -$4000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -126,000.00 |
| Sep 30, 2023 | 80,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | -446,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | -3.76 Mn |
| Mar 31, 2021 | 221,000.00 |